ArticlePloS one2024
A convenient analytic method for gel quantification using ImageJ paired with Python or R.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quantitative Analysis of CRISPR Encoding Plasmid DNA-Nanocarrier Interactions by Gel Electrophoresis and Densitometry.Methods in molecular biology (Clifton, N.J.) · 2027Article
- Cell Disruption and RNA Extraction fromInternational journal of molecular sciences · 2026Article
- GelInsight: Open-source software for large-sample DNA fragmentation quality control in gel electrophoresis images.PloS one · 2026Article
- Chitosan Nanoformulations of Mycosporine-like Amino Acid (MAA)-Rich Extracts fromInternational journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, due to the COVID-19 pandemic, there was a surge of research on mRNA therapeutics. The applications are broad and include vaccination, cancer therapy, protein replacement, and immune modulation. mRNA therapeutics have advantages over other nucleic acid therapies because of the reduced risk of mutagenesis. On the other hand, mRNA therapeutics have a large caveat due to its inherent instability, which makes it susceptible to degradation throughout all stages of production, storage, and in vivo application. Decades ago, agarose gel electrophoresis was developed to separate and resolve nucleic acids based on size. Since then, the evolution of image analysis tools, such as ImageJ, has facilitated semi-quantitative evaluation of concentration based on band intensity, and qualitative observation of RNA integrity from gel electrophoresis. Instruments utilizing capillary electrophoresis, like the Agilent 2100 Bioanalyzer, that use microchip linear acrylamide gel electrophoresis have been demonstrated to be superior to agarose gel electrophoresis in studying RNA quality. Due to the higher cost of usage, they are less accessible to the average lab than agarose electrophoresis. In this work, we review the fundamentals of mRNA assessment and propose a full-lane quantification (FLQ) method, which is a fast, simple, and inexpensive method to analyze RNA degradation from agarose gels using ImageJ paired with Python and R. This measures the area under the curve of the product peak, degradation zone, and a combined score to provide sensitive means to evaluate the degradation of mRNA. This method provides measures of the degradation profile within each lane comparable to an RNA integrity number from bioanalyzers. Using this cost-effective method, we demonstrate that the degradation index is a sensitive measure that reflects the degradation and preservation of mRNA patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.